TrumpRx is here and it helps, though a bit less than advertised [Fortune]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Fortune
The New Republic called it a “ Big Fat Scam ,” but it is now up to the public to decide, with it making its first appearance as a supposed market restructurer. Recommended Video For decades, the American government has played a powerful but disciplined role in healthcare markets. At first, it was a passive purchaser, then a coverage expander, and only recently has it become a price negotiator, albeit in a limited capacity. However, TrumpRx, which seeks for pharmaceutical companies to grant the U.S. “most favored nation” status, is a departure from these models and signals a continued shift toward government market interventionism. TrumpRx also emerges in a political environment where government intervention in drug pricing is no longer considered unacceptable. While the passage of the Inflation Reduction Act (IRA) marked a small first step toward addressing a malady, Trump has made government intrusion into market operations a standard tool for his version of the Republican Part
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Is Johnson & Johnson a Buy, Sell, or Hold in 2026? [Yahoo! Finance]Yahoo! Finance
- Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson to Participate in the Barclays 28th Annual Global Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson to Participate in the Barclays 28th Annual Global Healthcare ConferenceBusiness Wire
JNJ
Earnings
- 1/21/26 - Beat
JNJ
Sec Filings
- 2/11/26 - Form 4
- 2/11/26 - Form 4
- 2/11/26 - Form 4
- JNJ's page on the SEC website